ATE318606T1 - Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i - Google Patents

Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i

Info

Publication number
ATE318606T1
ATE318606T1 AT00911330T AT00911330T ATE318606T1 AT E318606 T1 ATE318606 T1 AT E318606T1 AT 00911330 T AT00911330 T AT 00911330T AT 00911330 T AT00911330 T AT 00911330T AT E318606 T1 ATE318606 T1 AT E318606T1
Authority
AT
Austria
Prior art keywords
cysteine protease
metal ion
allergies
prophylaxis
compositions
Prior art date
Application number
AT00911330T
Other languages
English (en)
Inventor
Mayumi Kotani
Akihito Fujita
Motonobu Matsumoto
Original Assignee
Sunstar Inc
Sunstar Suisse Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc, Sunstar Suisse Sa filed Critical Sunstar Inc
Application granted granted Critical
Publication of ATE318606T1 publication Critical patent/ATE318606T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Polymers & Plastics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT00911330T 1999-03-26 2000-03-24 Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i ATE318606T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8439599 1999-03-26
JP12363399 1999-04-30
JP17373199 1999-06-21

Publications (1)

Publication Number Publication Date
ATE318606T1 true ATE318606T1 (de) 2006-03-15

Family

ID=27304536

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911330T ATE318606T1 (de) 1999-03-26 2000-03-24 Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i

Country Status (8)

Country Link
US (1) US7211567B1 (de)
EP (1) EP1172109B1 (de)
JP (3) JP4873785B2 (de)
AT (1) ATE318606T1 (de)
CA (1) CA2368574C (de)
DE (1) DE60026279T2 (de)
ES (1) ES2258971T3 (de)
WO (1) WO2000057888A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910141B2 (en) 2005-03-03 2011-03-22 Sapporo Breweries Limited Antiallergic composition

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211567B1 (en) * 1999-03-26 2007-05-01 Sunstar, Inc. Composition for preventing and treating type I allergy
JP2002316937A (ja) * 2001-04-19 2002-10-31 Ichimaru Pharcos Co Ltd 植物抽出物含有抗アレルギー剤
JP3830813B2 (ja) * 2001-12-19 2006-10-11 丸善製薬株式会社 皮膚外用剤及び美容用飲食品
US20050142233A1 (en) 2002-03-27 2005-06-30 Hououdou Co., Ltd. Compositions for treating and/or preventing pollinosis
CN100400080C (zh) * 2002-03-27 2008-07-09 株式会社凤凰堂 治疗和/或预防花粉症用的组合物
US20040126351A1 (en) * 2002-12-26 2004-07-01 Avon Products, Inc. Topical composition having natural skin anti-irritant ingredient and method of use
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
JP2007176938A (ja) * 2005-11-30 2007-07-12 Shuzo Nakazono 油混合柿エキスの抽出方法
JP5296466B2 (ja) * 2008-09-18 2013-09-25 株式会社ファンケル Ｍｉｆ分泌抑制剤
JP5325727B2 (ja) * 2009-09-24 2013-10-23 株式会社武蔵野免疫研究所 センダングサ属植物抽出物含有組成物
JP2013526594A (ja) * 2010-05-24 2013-06-24 インデナ エッセ ピ ア 微生物感染の治療に使用するためのタマリンド種子多糖
ES2645245T3 (es) 2010-12-28 2017-12-04 Kamedis Ltd. Extractos vegetales para el tratamiento y prevención de infecciones
US10967031B2 (en) 2010-12-28 2021-04-06 Kamedis Ltd. Synergistic herbal compositions with prebiotic properties for treatment of skin infections, allergies and inflammation
ES2762196T3 (es) * 2011-02-21 2020-05-22 Innovate Ag Pty Ltd Control de plagas de insectos
KR101323068B1 (ko) * 2011-09-29 2013-10-29 주식회사 코리아나화장품 아왜나무 추출물을 유효성분으로 함유하는 화장료 조성물
EP2649991B1 (de) * 2012-04-13 2016-02-24 King Saud University Extrakte und isolierte Verbindungen aus Euphorbia granulata Forrsk. zur Behandlung von Colitis ulcerosa
DK2908834T3 (en) * 2012-10-18 2017-10-23 Montero Gida Sanayi Ve Ticaret As Hitherto UNKNOWN FORMS OF PLANT EXTRACTS
KR101479132B1 (ko) * 2012-11-28 2015-01-05 건국대학교 산학협력단 캄페롤 배당체의 제법 및 기능성성화장품으로서의 용도
CN105541932B (zh) * 2016-01-25 2017-12-15 南阳师范学院 从小蓟中提取的苯乙醇苷类化合物及其制备方法和用途
KR101881758B1 (ko) * 2016-07-29 2018-07-25 한국과학기술연구원 라릭스 시비리카 추출물을 포함하는 항알러지용 조성물
TWI796493B (zh) * 2018-06-22 2023-03-21 日商花王股份有限公司 經口組合物
FR3130609A1 (fr) 2021-12-21 2023-06-23 Basf Beauty Care Solutions France Sas Combinaison de l’Astragaline et la Miquélianine pour inhiber l’activité de la lipase de S aureus.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8628228D0 (en) 1986-11-26 1986-12-31 Inst Biolog Morya Dalnevostoch Composition inhibiting pathological addiction to alcohol
US4808574A (en) * 1986-12-03 1989-02-28 Nauchno-Issledovatelsky Institut Sadovodstva Composition inhibiting pathological addiction to alcohol
US5478579A (en) * 1991-02-06 1995-12-26 Biodyn Medical Research, Inc. Method for treatment of osteoporosis
US6350784B1 (en) 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
JPH0725761A (ja) 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
JPH07118151A (ja) * 1993-10-21 1995-05-09 Kureha Chem Ind Co Ltd アトピー性皮膚炎治療剤
DE19544905A1 (de) 1995-12-01 1997-06-05 Robugen Gmbh Verfahren zur Herstellung von Pflanzenextrakten
JPH09255583A (ja) 1996-03-25 1997-09-30 Yamamoto Koryo Kk 抗かゆみ剤
JPH1129561A (ja) * 1997-07-07 1999-02-02 Asahi Chem Ind Co Ltd 新規化合物ａｍ６１０５及びその製法
US6524625B2 (en) * 1998-06-30 2003-02-25 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyuto Physiologically active extract obtained from indigo plant polygonum tinctorium
US7211567B1 (en) * 1999-03-26 2007-05-01 Sunstar, Inc. Composition for preventing and treating type I allergy

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910141B2 (en) 2005-03-03 2011-03-22 Sapporo Breweries Limited Antiallergic composition

Also Published As

Publication number Publication date
JP2009173632A (ja) 2009-08-06
EP1172109A1 (de) 2002-01-16
EP1172109B1 (de) 2006-03-01
JP2012021009A (ja) 2012-02-02
EP1172109A9 (de) 2002-04-03
DE60026279D1 (de) 2006-04-27
CA2368574C (en) 2008-08-12
WO2000057888A1 (fr) 2000-10-05
CA2368574A1 (en) 2000-10-05
DE60026279T2 (de) 2006-10-12
JP4873785B2 (ja) 2012-02-08
ES2258971T3 (es) 2006-09-16
US7211567B1 (en) 2007-05-01

Similar Documents

Publication Publication Date Title
ATE318606T1 (de) Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i
ATE353880T1 (de) Neue verwendung von pyrimidin- oder triazin-2- carbonsäurenitrilen zur behandlung von krankheiten, die mit cysteinproteaseaktivität assoziiert sind, und neue pyridimidin-2- carbonsäurenitrilderivate
TR200002940T2 (tr) Parazitlerin sebep olduğu hastalıkların papain süperfamilyasından sistein proteazların inhibisyonu yoluyla tedavisi
ATE443043T1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
SE0201980D0 (sv) Novel compounds
DE69716823D1 (de) Thrombin-Inhibitoren als anticoagulierende Mittel
ATE345136T1 (de) Cysteinprotease-hemmer mit 2-cyano-4-amino- pyrimidinstruktur und cathepsin-k-hemmender wirkung zur behandlung von entzündungen und anderen erkrankungen
ATE405840T1 (de) Zusammensetzungen und verfahren zur stabilisierung von transthyretin und zur hemmung von transthyretin-fehlfaltung
ATE554756T1 (de) Kombination aus epothilon-analog und chemotherapeutika zur behandlung von proliferativen erkrankungen
DE60133029D1 (de) Mittel zur prävention oder behandlung von psoriasi
ATE244717T1 (de) Inhibitoren des impdh-enzyms
NO983688L (no) Serin-protease-inhibitorer
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
BR0312000A (pt) Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos
ATE333451T1 (de) Verwendung von nitrilenverbindungen als arztneimittel
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
DE60313803D1 (de) Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen
ATE428425T1 (de) Spla2-inhibitoren zur behandlung von arteriosklerose
ATE550039T1 (de) Mittel zur behandlung von glomerulären erkrankungen
ATE289204T1 (de) Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE59813914D1 (de) Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen
ATE311901T1 (de) Verwendung von tgf-beta inhibitoren zur behandlung von cerebralen krankheiten
DE69932434D1 (de) Prophylaxe und Behandlung von autoimmunen Entmyelinisierungserkrankungen durch Fas-antagonisten
DE50206173D1 (de) Antiglaukomatoses mittel und dessen verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties